U.S. Food and Drug Administration

Evaluate appropriate regulatory pathway for CBD products beyond existing food and dietary supplement frameworks

Reduce lead in fruit-based baby foods

Reduce lead in root vegetables and dry infant cereals

Complete regulatory review of TransCon CNP with PDUFA target action date

FDA supports AI-based medical devices and healthcare digitization programs to accelerate AI integration in U.S. healthcare

FDA aims to accelerate regenerative medicine advancement through expedited approval pathways while maintaining rigorous safety and efficacy standards

Speed up the development of safe, effective, and innovative medical devices critical to public health through the TPLC Advisory Program Pilot

Review CagriSema regulatory application for weight management

Expedite development and review timelines of drugs that demonstrate potential to treat serious conditions through Fast Track designation program

Set daily sodium intake target for food categories including salad dressings